Brii Biosciences Ltd
F:7SS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brii Biosciences Ltd
F:7SS
|
CN |
|
B
|
BAVARIA Industries Group AG
XMUN:B8A
|
DE |
|
B
|
Bechtle AG
XMUN:BC8
|
DE |
|
C
|
Cypress Development Corp
F:C1Z1
|
CA |
|
R
|
Rockland Resources Ltd
OTC:BERLF
|
CA |
|
M
|
Maanshan Iron & Steel Co Ltd
XMUN:YM9A
|
CN |
|
Tekmar Group PLC
F:6UA
|
UK |
|
Greatview Aseptic Packaging Co Ltd
OTC:GRVWF
|
CN |
|
Bioatla Inc
OTC:BCAB
|
US |
|
Profire Energy Inc
F:PFR
|
US |
|
Vef AB (publ)
F:0TX
|
SE |
|
B
|
Bank of Jinzhou Co Ltd
F:2JI
|
CN |
|
Biofrontera AG
LSE:0DOL
|
DE |
|
Metro Mining Ltd
ASX:MMIDA
|
AU |
|
Guangzhou Automobile Group Co Ltd
F:02G
|
CN |
|
B
|
Biofrontera AG
XMUN:B8F
|
DE |
|
Surge Copper Corp
F:G6D2
|
CA |
|
E
|
Esprit Holdings Ltd
XMUN:ESHB
|
HK |
Bankruptcy Probability
Brii Biosciences Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Brii Biosciences Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Brii Biosciences Ltd
HKEX:2137
|
659.9m HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
61.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Brii Biosciences Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Brii Biosciences Ltd has total debt of 3.9m CNY. This includes both short-term (0 CNY) and long-term (3.9m CNY) debt.
You can find a full breakdown on its Balance Sheet.
